Variant report
Variant | esv20241 |
---|---|
Chromosome Location | chr12:22322309-22326692 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs552640259 | chr12:22322312-22322313 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs66529819 | chr12:22322317-22322318 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs538222924 | chr12:22322340-22322341 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs146210928 | chr12:22322418-22322419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs7297849 | chr12:22322420-22322421 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs7297942 | chr12:22322466-22322467 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs7298047 | chr12:22322495-22322496 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs75101565 | chr12:22322512-22322513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546120156 | chr12:22322515-22322516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76075799 | chr12:22322519-22322520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs386375862 | chr12:22322529-22322530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs12227640 | chr12:22322531-22322532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs7963642 | chr12:22322558-22322559 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs374438056 | chr12:22322625-22322626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541966372 | chr12:22322638-22322639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs368898683 | chr12:22322642-22322643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs117607517 | chr12:22322674-22322675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375801939 | chr12:22322681-22322682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs527291580 | chr12:22322715-22322716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs189924787 | chr12:22322729-22322730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs372287162 | chr12:22322730-22322731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs533144925 | chr12:22322769-22322770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7298331 | chr12:22322789-22322790 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs147878663 | chr12:22325211-22325212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2009625 | chr12:22325245-22325246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376925933 | chr12:22325332-22325333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs76415721 | chr12:22325393-22325394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148942121 | chr12:22325402-22325403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs143720367 | chr12:22325424-22325425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556885234 | chr12:22325437-22325438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs573317365 | chr12:22325438-22325439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536101583 | chr12:22325455-22325456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs151086384 | chr12:22325488-22325489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs79948651 | chr12:22325496-22325497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs79802701 | chr12:22325501-22325502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs79812459 | chr12:22325503-22325504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs71448638 | chr12:22325528-22325529 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs138142124 | chr12:22325529-22325530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs377298840 | chr12:22325535-22325536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs5023581 | chr12:22325568-22325569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs141060675 | chr12:22325642-22325643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs186815042 | chr12:22325708-22325709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs77112903 | chr12:22325755-22325756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs537804928 | chr12:22325761-22325762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs201873354 | chr12:22325795-22325796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560138609 | chr12:22325871-22325872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528659849 | chr12:22325876-22325877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs10541523 | chr12:22325877-22325878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs551975767 | chr12:22325878-22325879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs371192038 | chr12:22325894-22325895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Malignant germ cell tumour | 17285132 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 16397240 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22102821 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Lung cancer | 18438408 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 22048815 | CNVD |
Malignant peripheral nerve sheath tumor | 19844265 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Heart disease | 21282601 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 17925434 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Gastric cancer | 24379144 | CNVD |
Gastric cancer | 19545448 | CNVD |
Lung cancer | 20031968 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung adenocarcinoma | 19826477 | CNVD |
Lung cancer | 19525976 | CNVD |
Lung cancer | 19826477 | CNVD |
Non-small cell lung cancer | 19451690 | CNVD |
Non-small cell lung cancer | 17504988 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Lung cancer | 19671679 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:22318200-22322400 | Weak transcription | Primary T cells fromperipheralblood | blood |
2 | chr12:22321800-22322800 | Enhancers | Primary T cells from cord blood | blood |
3 | chr12:22322000-22322400 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
4 | chr12:22322200-22322600 | Enhancers | Primary B cells from peripheral blood | blood |
5 | chr12:22322200-22322600 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
6 | chr12:22322200-22322600 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
7 | chr12:22322200-22322800 | Enhancers | Fetal Thymus | thymus |
8 | chr12:22322400-22322800 | Enhancers | Primary T cells fromperipheralblood | blood |
9 | chr12:22325200-22326000 | Enhancers | HSMMtube | muscle |
10 | chr12:22325400-22325800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
11 | chr12:22326400-22326800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |